Cephalexin Oral Suspension Recalled for Incorrect Dosage Label
Bryant Ranch Prepack is recalling Cephalexin oral suspension because the back label incorrectly states the bottle contains 5g instead of 10g. No illnesses have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class III recalls are typically scored 1 or 2 per the rubric. This labeling error involving incorrect dosage information qualifies as a 'minor labeling error,' and no illnesses have been reported, supporting a Moderate (2) classification.
Plain-English summary
Bryant Ranch Prepack, Inc. is recalling Cephalexin for Oral Suspension, USP 250mg/5mL (lot numbers 235287, 235629, 235805, 236292, 237022, 237308, 237748, expiring 12/31/2025). The product was distributed nationwide in the USA.
The back label incorrectly states 'Each contains: cephalexin monohydrate, USP equivalent to 5g' when the correct statement should be 'Each Bottle contains: cephalexin monohydrate, USP equivalent to 10g.' This labeling discrepancy understates the actual dosage content of each bottle and could cause confusion among patients and healthcare providers.
No illnesses or adverse effects have been reported. Consumers should consult their healthcare provider or pharmacist if they have questions about the correct dosage.
The recalled product
- Product
- CEPHALEXIN (CEPHALEXIN)
- Brand
- CEPHALEXIN
- Manufacturer
- Bryant Ranch Prepack, Inc.
- Category
- Drug
- Hazard
- mis-labeling
- dosage-error
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot: 235287
- 235629
- 235805
- 236292
- 237022
- 237308
- 237748
- Exp: 12/31/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CEPHALEXIN
- ModerateCephalexin Oral Suspension Recalled for Out-of-Specification Impurity
FDA (Drugs) · 2025-06-18
- ModerateCephalexin Oral Suspension Recalled for Chemical Impurity
FDA (Drugs) · 2025-06-18
- ModerateCephalexin oral suspension recalled for incorrect label dosage amount
FDA (Drugs) · 2024-06-12
- LowCephalexin Oral Suspension Recalled for Incorrect Labeling and Missing Dosage Information
FDA (Drugs) · 2024-06-12
- LowCephalexin for Oral Suspension Recalled for Back Label Error
FDA (Drugs) · 2024-06-12
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27